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Abstract
Background: Health information has become readily accessible through mass media, and people are playing a
more active and autonomous role in their health. Much of the health information that was previously only available
to health professionals is now directly accessible to the public. Consequently, people often navigate vast amounts
of health information on their own, typically with little knowledge about how to evaluate it or the need to do so.
Health information remains essentially unregulated, and widespread problems and concerns with the quality of
health information have been noted. In addition to the variable quality of health information, inconsistent and/or
inappropriate use of related terminology (e.g. ‘evidence-based’ and ‘clinically proven’) can be confusing to the
public, who are ill-prepared to critically examine claims.
The general public are not trained in the fundamentals of health research and do not typically possess the knowledge
and skills to evaluate the accuracy and completeness of information about health interventions. Without this, the
public are vulnerable to acting on inaccurate or incomplete health information and making ill-informed health
decisions. With this review, we intend to identify and assess educational interventions which have been
designed to improve people’s ability to understand key concepts relevant to evaluating claims about the effects of
health interventions.
Methods/design: This systematic review of the literature will use a search strategy that has been developed in
conjunction with a Health Sciences Librarian who has expertise in systematic review searching to identify relevant
studies. Databases to be searched include the following: the Cochrane Central Register of Controlled Trials, MEDLINE,
EMBASE, CINAHL, and ERIC. Attempts to identify unpublished studies and ongoing trials will also be made. Two review
authors will independently screen search results and assess studies for eligibility. Studies which aim to improve
participants’ understanding of the key concepts relevant to evaluating the effects (or the interpretation of results) of
health interventions will be included. Randomised trials, non-randomised trials, controlled before and after studies,
controlled studies with only post-test measures, and interrupted time series studies will be eligible for inclusion. We will
contact study authors to clarify any missing details/data. Due to the nature of the systematic review question and the
expectation of heterogeneity in study design, interventions, and outcomes, we intend to take a narrative approach to
data synthesis.
Systematic review registration: PROSPEROCRD42016033103
Keywords: Consumer, Education, Health information, Health literacy, Critical health literacy, Critical appraisal
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Background
Health information, and misinformation, is readily
accessible to people, particularly through mass media
and the Internet [1–6]. Due to the ease with which large
amounts of health information can now be accessed,
people are playing a more active and autonomous role in
their health [7]. The health information that people access
can affect their health decisions and behaviours—for
example, from how they maintain their health and cope
with a chronic condition to what decisions are made
about how to treat an illness or whether to consult a
health professional [8, 9].
As well as websites and traditional information sources
such as magazines, radio, and television, health informa-
tion is also available on social media such as Facebook
[10], YouTube health channels, and Twitter [11]. Regard-
less of the type of media, health information remains es-
sentially unregulated and problems and concerns with the
quality of health information have been noted [2, 12, 13].
Traditionally, people relied on health professionals as
intermediaries between themselves and health informa-
tion. However, health information that was previously
only available to health professionals is now directly
accessible to the public. Consequently, people often
navigate vast amounts of information on their own,
typically with little knowledge about how to evaluate it
or the need to do so [14].
Health interventions are one of the most commonly
researched health topics [8, 9], yet the quality of health
information is variable [5]. Some interventions are
promoted using phrases such as ‘evidence-based’ and
‘clinically proven’. Phrases such as these are intended to
convince people of an intervention’s effectiveness, and
when the claims are not warranted, their use can be mis-
leading. Some of the other complexities that can influence
people’s decision-making about interventions are that
some people tend to rely on anecdotes rather than infor-
mation derived from research [15, 16], some overrate the
trustworthiness of the health information they find and
most overestimate the benefits and underestimate the
harms of interventions [17]. Belief in false or
unsubstantiated claims about interventions may result in
people receiving inappropriate interventions that are at
best ineffective and at worst harmful, as well as wasting
health care resources. Conversely, not believing claims
that are based on reliable research evidence about inter-
ventions can also cause harm, such as through inappropri-
ate treatments or delays in seeking appropriate health care
[18–21] or choosing ineffective treatments over effective
ones [22].
Health information may be misleading, misinterpreted,
or leave people confused [2, 23].
Consumers require skills in assessing the quality of
both general health information and information about
health interventions and their effectiveness. Without
specific education about key concepts relevant to evalu-
ating the effects of health interventions and how to in-
terpret research results, people are, irrespective of their
level of education, vulnerable to believing health claims
and may make health decisions based upon information
that is inaccurate, incomplete, or even harmful [19, 22].
Considering its nature and extensive reach, regulation of
health information on the Internet, or other sources, is
impossible. However, providing people with knowledge
about key concepts in evaluating information about
health interventions may assist them to evaluate the
accuracy of intervention claims and to make informed
decisions. Unlike most health professionals, the general
public are typically not trained to evaluate the accuracy
and completeness of information about health interven-
tions [14].
Most of the existing research in the area of helping
people to understand health information has focused on
the traditional skills associated with health literacy, such
as reading, numeracy, and oral literacy. Limitations in
these skills can impact upon people’s ability to navigate
the health system and are associated with poorer
outcomes and decreased uptake of provided health
services [24]. Previous systematic reviews have examined
the effectiveness of related interventions such as teaching
online health literacy to the general public [25] and critical
appraisal skills to health professionals [26], and a review
to assess the effects of educational interventions on critical
appraisal abilities in school students is currently underway
[27]. Yet, to our knowledge, there is no systematic review
of studies of educational interventions designed to
improve critical appraisal abilities in the general public. In
this review, we will identify, appraise, and synthesise
studies that have evaluated educational interventions
which cover one or more key concepts in assessing the
effects of health intervention concepts in the critical
appraisal of health intervention claims.
Objectives
The objective of this systematic review is to assess the
effectiveness of educational interventions designed to im-
prove people’s understanding of key concepts (described
below) when evaluating claims about the effects of health
interventions.
Methods
Eligibility criteria
Study designs
Randomised trials, non-randomised trials, controlled
before and after studies, controlled studies with only
post-test measures, and interrupted time series studies
will be eligible for inclusion. As this type of educational
intervention is relatively new, we anticipate that there
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will be few randomised trials, but there may be other
comparative studies.
Participants
Studies of educational interventions directed at the
following populations will be eligible for inclusion: patients,
members of the general public, journalists, and school or
university students who are not undertaking health studies.
There is no minimum or maximum limit on the age of par-
ticipants. Studies in which all participants are either tertiary
health students and/or health professionals will be excluded
from the review, as an educational intervention provided
to them on this topic is most likely designed to assist them
to perform decision-making with their patients, rather
than decision-making regarding their own health.
Intervention
Any educational intervention which aims to help the
participants understand one or more of the key concepts
that are relevant to evaluating the effects of health inter-
ventions and/or the interpretation of research results
will be eligible. The educational intervention might be
focused and only address one concept (such as the
rationale for randomisation) or it may address multiple
concepts. A list of the key concepts necessary to assess
claims of the effects of a treatment will inform the
concepts eligible for this review. This concept list has
been developed by Austvoll-Dahlgren and colleagues
[24] based on the contents of Testing Treatments [28], a
book written for the public, and consultations with a
wide range of commentators. Examples of concepts that
may be covered include the following: how and why
health research is performed, different kinds of study
types and ‘evidence’, what makes a study valid and
reliable, concepts such as the role of chance, the role of
randomised trials and systematic reviews, and how to
interpret study results. More specific concepts could
include the following: PICO questions, randomisation,
concealed allocation, equipoise, comparison groups, the
role of blinding in outcome assessment, placebos, under-
standing outcomes (e.g. absolute vs relative risk), and
bias and conflicts of interest in research.
This information may either be the focus of the interven-
tion or used as an example/scenario to illustrate broader
scientific knowledge (e.g. causation vs association). The
examples/scenarios used must be within the context of
health information or claims, health conditions, the human
body, and/or conventional, complementary, or alterna-
tive medical treatments to be eligible. There will be
no restriction on other characteristics of the educational
interventions, such as the mode of delivery (e.g. face-to-
face or remotely, by the internet or written materials),
whether the intervention was delivered in a group or one-
to-one, the intensity and duration of the intervention
(such as one session or multiple sessions), and whether it
is provided using didactic or interactive methods.
Comparators
There will be no restriction on the comparator used in
eligible studies. For example, this may include no
intervention, an ‘attention control’ intervention, or an
educational intervention that covers different topics.
Outcomes
Primary outcomes will include any measures that evaluate
knowledge or understanding of concepts relevant to
evaluating the effects of, or claims about, health inter-
ventions. Secondary outcomes will be any measures of
application of the knowledge taught, through demon-
strations of relevant skills, behaviours, and attitudes,
as well as satisfaction with the intervention.
Timing
There will be no specific eligibility criteria for inclusion
based on when post-intervention outcomes are measured.
Setting
There will be no restrictions by type of setting.
Language
There will be no language restrictions in our search
strategy. We will attempt to translate potentially eligible
non-English articles via Google Translate or by a native
speaker of the language of the article. In the event that
an article is eligible but unable to be satisfactorily trans-
lated, we will present the title and author details in a
supplementary appendix.
Information sources
Electronic databases
Search strategies will be developed using appropriate
Medical Subject Headings (MeSH) and text words. We
will search the following electronic databases:
 The Cochrane Central Register of Controlled Trials
(CENTRAL The Cochrane Library, Issue 10 of 12,
October 2015)
 Cochrane Consumers and Communication Review
Group Specialised Register (accessed November 2015)
 MEDLINE (OvidSP) (1946 to November 2015)
 Embase.com (1966 to November 2015)
 CINAHL (1982 to November 2015)
 Web of Science Core Collection (1900 to November
2015)
 ERIC (1990 to November 2015)
 Searches of the International Clinical Trials Register
(ICTRP) Search Portal and ClinicalTrials.gov will be
conducted to identify trials that are ongoing (present).
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Other resources
Sources of grey literature that will be searched are as
follows:
Relevant organisations, such as the following:
 Health Literacy Europe (healthliteracyeurope.net)
 Health Literacy UK (healthliteracy.org.uk)
 Health Literacy Research Network
(healthliteracy.net.au)
Relevant theses and dissertations, via the following:
 National Library of Australia’s Trove service
(http://trove.nla.gov.au/)
 Networked Digital Library of Theses and
Dissertations (http://www.ndltd.org/)
 ProQuest Digital Dissertations and Theses (http://
www.proquest.com/products-services/pqdt.html)
We will perform forward and backward citation
searching of eligible studies. We will attempt to locate
unpublished studies by contacting published authors in
the field and asking if they are aware of ongoing and
unpublished studies.
Search strategy
No date or language limits will be imposed on the search.
The specific search strategies were created by a Health
Sciences Librarian with expertise in systematic review
searching. The MEDLINE (OvidSP) strategy (shown in
the Appendix) will be adapted for the other databases
Study records
Data management
All search results will be merged into the reference man-
agement software EndNote, and duplicate records of the
same report will be removed using the Centre for
Research in Evidence-Based Practice Systematic Review
Assistant ‘deduplication tool’ [29].
Selection process
Two researchers will independently assess the eligibility
of studies by screening titles and abstracts for potential
inclusion according to predefined selection criteria.
Studies judged to be potentially relevant will be retrieved
in full text for further analysis. Any disagreements in
judgement will be resolved by discussion to reach a
consensus or, if this is not possible, with a third review
author until consensus is reached. If further information
about the study is required in order to make a decision
about its eligibility, an attempt will be made to contact
the study corresponding author(s). If a response is not
received after three reminders are sent and/or after
attempting to contact another author of the paper with
no response, the study will be excluded. We will also
provide citation details and any available information
about ongoing studies.
Data collection process
Two review authors (LC and TH) will extract data inde-
pendently from included studies. Where necessary, study
authors will be contacted to provide additional informa-
tion about the study method or results. All extracted
data will be entered into Review Manager (RevMan
2012) by one review author (LC) and will be checked
independently by a second review author (TH) for
accuracy against the data extraction sheets. Any discrep-
ancies will be resolved by discussion, or through consult-
ation with a third author (CDM), until consensus is
reached.
Data items
Where possible, extracted data will include study details,
demographic, methodology, intervention and comparison
details, and all relevant outcomes and results:
Study details: aim, design, funding sources
Participants: recruitment, inclusion/exclusion criteria,
geographic location, total numbers (including those
excluded, withdrawn, or lost to follow-up), age, gender,
ethnicity, health problems, educational attainment, and
socioeconomic status.
Intervention: theoretical basis, aim, content, method of
delivery and other format details, where intervention
was provided, details of materials used in the
intervention and if/where they can be accessed,
duration and schedule of intervention, details of those
who provided the intervention, and intervention fidelity
(including any monitoring of this throughout the
study).
Control: details of the control condition and, if an
‘active comparator’, details of it as per the elements
recorded for the experimental intervention.
Outcomes: primary and secondary measures, methods
used to collect outcome data, validity and reliability of
outcome measures, methods of follow-up for non-
respondents, and timing of outcome assessment
Results: data (descriptive statistics and summary
results) for each eligible outcome measure.
Outcomes and prioritisation
Primary outcomes will demonstrate an understanding of
the knowledge taught and will include any measures that
evaluate knowledge or understanding of concepts relevant
to evaluating the effects of, or claims about, health inter-
ventions. For example, this may include the following:
– Understanding the need for critical appraisal
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– Recognising the need to consider all relevant and
reliable evidence
– Understanding concepts that underpin health
intervention research (such as randomisation
and causation)
– Recognising the need for systematic reviews,
preferably of randomised trials
– Understanding the role of chance and understanding
the results of trials and systematic reviews and
– Judging whether a trial or systematic review is relevant
Secondary outcomes will demonstrate an application
of the knowledge taught and will include any measures
of the following:
– Confidence in applying any of the knowledge
concepts, for example, this might be demonstrated
through rating the quality of health information and
intervention claims in academic or non-academic
sources (such as media stories, advertisements,
and websites)
– Behaviours (actual or hypothetical) related to
making decisions about health interventions,
such as whether to have a particular intervention
– Attitudes towards the need for critically appraising
health information and intervention claims and
– Attitudes towards, satisfaction with, or completion
of the intervention
Due to the nature of this review, we expect variety in
the types of outcome measures used. For example, the
knowledge outcome may be assessed through multiple
choice questions or written responses to scenarios. The
timing of when the measures are administered is also
likely to vary between studies. For example, some out-
comes may be assessed pre- and post-intervention and
others at only post-intervention. These variations are
likely to limit pooling of data and restrict synthesis to a
narrative summary.
Risk of bias in included studies
To assess and report on the possible methodological risk
of bias of included studies, ACROBAT-NRSI (A Cochrane
Risk Of Bias Assessment Tool: for Non-Randomized Stud-
ies of Interventions) guidelines [30] will be used. These
guidelines are a modified version of the Cochrane risk of
bias tool [31] and are specifically designed for non-
randomised studies of interventions. The topics will
include the following: sequence generation, allocation
concealment, blinding, incomplete outcome data (e.g.
dropouts and withdrawals), selective outcome reporting,
and other areas of bias. For each domain in the tool, the
procedures undertaken for each study will be described.
Each study will be rated as ‘high risk’ or ‘low risk’ of bias
based on a judgement of the gathered information. If there
is insufficient detail reported in the study, the risk of bias
will be classified as ‘unclear’ and the original study investi-
gators will be contacted for more information. These
judgements will be made independently by two review
authors (LC and TH) based on the criteria for judging the
risk of bias [32]. Disagreements will be resolved by
discussion or, if necessary, through arbitration with a
third author.
Data synthesis
Where studies are sufficiently homogeneous in terms of
design and comparator, we will conduct meta-analyses
using a random-effects model. However, due to the nature
of this study (with expected substantial heterogeneity
detected across included studies, in relation to study
design, intervention design and type, and outcomes), it is
anticipated that the results will not be conducive for a
meta-analysis. With the expectation of heterogeneic
results, we intend to tabulate results and present an
appropriately clustered descriptive synthesis of the eligible
studies.
In studies which compare more than one intervention,
each will be compared separately to no intervention/
control and also with one another.
Dealing with missing data
Attempts will be made to contact study authors to obtain
any missing data (e.g. participant, intervention, or out-
come details). Analyses will be conducted (where possible)
on an intention-to-treat basis; alternatively, data will be
analysed as reported. Losses to follow-up will be reported
and assessed as a potential source of bias.
Assessment of heterogeneity
Where studies are considered appropriately similar
(based upon populations, interventions, and outcomes)
to allow pooling of data using meta-analysis, the degree
of heterogeneity will be assessed by visual inspection of
forest plots and also by the Chi2 test for heterogeneity.
Heterogeneity will be quantified using the I2 statistic.
The I2 value (with 50 % or more representing substantial
levels of heterogeneity) will be interpreted in light of the
size and direction of effects and the strength of the
evidence for heterogeneity, based on the P value from
the Chi2 test [33].
Sensitivity analysis
If there is a sufficient number of studies, we will conduct
a sensitivity analysis as appropriate (for example, results
from randomised trials vs results from other study
designs).
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Assessment of meta-bias(es)
Reporting bias will be assessed qualitatively based
upon the characteristics of the included studies (e.g.
if only small studies that indicate positive findings are
identified for inclusion) and also based upon the in-
formation that we obtain from experts and authors
which suggests that relevant studies exist yet remain
unpublished. If a sufficient number studies (at least
10) are identified for inclusion in the review, we will
construct a funnel plot to examine small study
effects, which may demonstrate the presence of publi-
cation bias. Funnel plot asymmetry will be tested
formally, with the selection of test based on the
advice in Higgins and Green [33], remaining mindful
of the fact that there may be several reasons for
funnel plot asymmetry when interpreting the results.
Strength of evidence: confidence in cumulative estimate
Where possible, the quality of the evidence will be
assessed and reported using the Grading of Recom-
mendations Assessment, Development and Evaluation
(GRADE) working group methodology. The quality of
evidence will be assessed across the domains of risk
of bias, consistency, directness, precision, and publi-
cation bias. Quality will be considered either as high
(further research is very unlikely to change our confi-
dence in the estimate of effect), moderate (further is
likely to have an important impact on our confidence
in the estimate of effect and may change the esti-
mate), low (further research is very likely to have an
important impact on our confidence in the estimate
of effect and is likely to change the estimate), or very
low (very uncertain about the estimate of effect). Two
authors (LC and TH) will independently assess the
quality of the evidence as implemented and described
in the GRADEprofiler (GRADEpro) software.
Discussion
As people seek health information more actively and
independently, knowledge about the key concepts that
should be considered when evaluating claims about the
effects of health interventions may assist people to make
appropriately informed decisions. An understanding of
the effects of existing interventions that aim to provide
this type of education will be useful in informing the
development of future educational interventions.
Additionally, if few eligible studies are identified, this
review will draw attention to an important area that
requires further research effort.
Presenting and reporting of results
This protocol follows the Preferred Reporting Items
for Systematic Review and Meta-Analysis Protocols
(PRISMA-P) 2015 Statement [34]. We will present
the results of this review according to the Preferred
Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) guidelines, using a flow diagram
to report the identification and selection of studies.
The relevant outcomes and characteristics of each
study will be reported in summary tables. Where
statistical pooling is not possible, the findings will be
alternatively presented in narrative form including
tables and figures to aid in data presentation where
appropriate.
Interpretation of findings
The results of the review will be discussed in the context
of the quality of the evidence, the limitations of the
review, and the strengths of findings as well as their
implications for current practice and future research
directions.
Appendix
Medline search (Ovid interface)
exp Persons/OR exp Patients/OR (People OR Patient
OR Patients OR People OR Schoolchildren OR Student
OR Students OR Public OR Consumer OR Consumers
OR Participant OR Participants).tw.
AND
exp Health Education/OR exp Teaching/OR Educa-
tion.tw. OR Educational.tw. OR Teaching.tw. OR Taught.tw.
OR Train.tw. OR Trained.tw. OR Training.tw. OR Work-
shop.tw. OR Workshops.tw.
AND
((exp Evidence-Based practice/OR exp Information
literacy/) AND (Understand OR Understanding OR
Competency OR Competencies OR Appraise OR
Appraisal OR Skill OR Skills OR Evaluate OR Evaluation
OR Knowledge).tw.
OR
(Evidence based OR Evidence-based OR Critical OR
Critically OR Health risk OR Health risks OR Randomisa-
tion OR Randomization OR Control group OR Compari-
son group OR Health information OR Health literacy OR
Health information OR Healthcare information OR
Medical information OR Health advice OR Healthcare
advice OR Medical advice OR Health research OR Health-
care research or Medical research OR Statistics OR Con-
trolled trial OR Controlled trial OR Clinical trial OR
Clinical trials OR RCT OR RCTs OR Systematic review
OR Systematic reviews).tw. adj2 (Understand OR Under-
standing OR Competency OR Competencies OR Appraise
OR Appraisal OR Skill OR Skills OR Knowledge OR
Evaluate OR Evaluating OR Evaluation OR Assess OR
Assessing OR Think OR Thinking).tw.)
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AND
(Randomized Controlled Trial or Controlled Clinical
Trial or Multicenter Study).pt. or exp Epidemiologic
Studies/or Program Evaluation/or Pilot Projects/or
(Randomised or Randomized or Randomise or
Randomize or Randomly or Random allocation).tw.
OR ((Group OR Groups) adj2 (random* or between
or control or intervention)).ab. OR Controlled
trial.tw. or (intervention* or controlled or control
group or compare or comparison* or compared or
((prospectiv* or crossover) adj2 (study or studies or
design)) or (before adj2 after) or (pre adj2 post) or
pretest or pre test or posttest or post test or quasiex-
periment* or time series or quasi experiment* or
evaluat* OR effectiveness or impact or time series or
time point? or repeated measur*).tw. or Observational.tw.
or Observe.tw. or Observation.tw. or Observing.tw. or
Survey.tw. or Surveys.tw. or Surveyed.tw. OR Inter-
views.tw. OR Comparison.tw.
NOT
exp Health Personnel/OR exp Education, Professional/
OR exp Students, Health Occupations/
OR
Review.pt. OR Meta Analysis.pt. OR News.pt. OR
Comment.pt. OR Editorial.pt. OR Letter.pt. OR cochrane
database of systematic reviews.jn. OR comment on.cm.
OR (systematic review or literature review).ti.
NOT
exp Animals/not (exp Animals/and Humans/).
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